Triangle Pharmaceuticals
Durham
About Triangle Pharmaceuticals
Triangle Pharmaceuticals develops new drug candidates primarily in the antiviral area, with a particular focus on therapies for HIV, including AIDS, and the hepatitis B virus.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Funding stage: M&A
- Last round: Pre-Seed (Jan 1995)
- Website: tripharm.com
- Phone: (919)493-5980
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/triangle-pharmaceuticals-2884770 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.